Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient

Multiple Sclerosis Journal

Volumn 19, Issue 11, 2013, Pages 1551-1552

  Lysandropoulos, Andreas P ^a   Benghiat, Fleur ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CORTICOSTEROID DERIVATIVE; FINGOLIMOD; HAPTOGLOBIN; HEMOGLOBIN; IMMUNOGLOBULIN G; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE;

ADULT; AUTOIMMUNE HEMOLYTIC ANEMIA; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION; BONE MARROW EXAMINATION; CASE REPORT; COOMBS TEST; CORTICOSTEROID THERAPY; DRUG WITHDRAWAL; EMERGENCY WARD; FATIGUE; FEVER; HEMOGLOBIN BLOOD LEVEL; HUMAN; JAUNDICE; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; MULTIPLE SCLEROSIS; NAUSEA; PROTEIN BLOOD LEVEL; RETICULOCYTE;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS; PROPYLENE GLYCOLS; SPHINGOSINE; YOUNG ADULT;

EID: 84884575436     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513493035     Document Type: Letter

References (5)

1. Liesveld JL, Rowe JM, Lichtman MA. Variability of the erythropoietic response in autoimmune hemolytic anemia: Analysis of 109 cases. Blood. 1987 ; 69: 820-826
2. Garratty G. Immune hemolytic anemia caused by drugs. Expert Opin Drug Saf. 2012 ; 11: 635-642
3. Eberhard M, Ferlinz K, Alizzi K, et al. FTY720-induced suicidal erythrocyte death. Cell Physiol Biochem. 2010 ; 26: 761-766
4. van der Giet M, Tölle M, Kleuser B. Relevance and potential of sphingosine-1-phopshate in vascular inflammatory disease. Biol Chem. 2008 ; 389: 1381-1390
5. Kihara A, Igarashi Y. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720. Biochim Biophys Acta. 2008 ; 1781: 496-502